Market Tracker

04/21 8:55am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.41
Delayed Data
As of Apr 20
 -0.06 / -0.45%
Today’s Change
7.09
Today|||52-Week Range
13.68
+61.57%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close13.47
Today’s open13.52
Day’s range13.27 - 13.63
Volume484,782
Average volume (3 months)561,978
Market cap$627.3M
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-62.50%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio34.1
Price/Sales2.87
Price/Book8.08

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.02+0.34%
VTLVital Therapies Inc+0.40+1.49%
FLMLFlamel Technologies ...+0.04+0.25%
TBPHTheravance Biopharma...+0.22+1.22%
Data as of 04/20/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts